Jonas Salk | Academic Influence

Jonas Salk's AcademicInfluence.com Rankings

Jonas Salk

Philosophy

#1084

World Rank

#2041

Historical Rank

#454

USA Rank

Logic

#1408

World Rank

#2155

Historical Rank

#423

USA Rank

philosophy Degrees

Download Badge

Philosophy

Jonas Salk's Degrees

Doctorate Medicine New York University

Why Is Jonas Salk Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Jonas Edward Salk was an American virologist and medical researcher who developed one of the first successful polio vaccines. He was born in New York City and attended the City College of New York and New York University School of Medicine.

(See a Problem?)

Jonas Salk's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A Simplified Procedure for Titrating Hemagglutinating Capacity of Influenza-Virus and the Corresponding Antibody (1944) (403)
Experimental allergic encephalomyelitis. An encephalitogenic basic protein from bovine myelin. (1969) (376)
A strategy for prophylactic vaccination against HIV. (1993) (210)
Control of influenza and poliomyelitis with killed virus vaccines. (1977) (172)
Formaldehyde treatment and safety testing of experimental poliomyelitis vaccines. (1954) (159)
Prospects for the control of AIDS by immunizing seropositive individuals (1987) (150)
Use of color change of phenol red as the indicator in titrating poliomyelitis virus or its antibody in a tissue-culture system. (1954) (112)
Experience with Vaccination Against Influenza in the Spring of 1947: A Preliminary Report. (1947) (96)
Standardization of poliovirus neutralizing antibody tests. (1984) (93)
THE USE OF ADJUVANTS IN STUDIES ON INFLUENZA IMMUNIZATION (1952) (87)
A CLINICAL, EPIDEMIOLOGICAL AND IMMUNOLOGICAL EVALUATION OP VACCINATION AGAINST EPIDEMIC INFLUENZA (1945) (80)
Use of adjuvants in studies on influenza immunization. III. Degree of persistence of antibody in human subjects two years after vaccination. (1953) (79)
Considerations in the preparation and use of poliomyelitis virus vaccine. (1955) (77)
The immunology of new generation vaccines. (1987) (77)
Anatomy of Reality: Merging of Intuition and Reason (1983) (65)
The survival of the wisest (1973) (63)
The protective effect of vaccination against epidemic influenza B. (1946) (63)
Protective Effect of Vaccination Against Induced Influenza A.∗ (1944) (60)
Initial studies on active immunization of HIV-infected subjects using a gp120-depleted HIV-1 Immunogen: long-term follow-up. (1996) (59)
A REVIEW OF THEORETICAL, EXPERIMENTAL, AND PRACTICAL CONSIDERATIONS IN THE USE OF FORMALDEHYDE FOR THE INACTIVATION OF POLIOVIRUS * (1960) (55)
A SIMPLIFIED PROCEDURE FOR THE CONCENTRATION AND PURIFICATION OF INFLUENZA VIRUS. (1942) (54)
PROTECTIVE EFFECT OF VACCINATION AGAINST INDUCED INFLUENZA A. (1945) (51)
Studies in human subjects on active immunization against poliomyelitis. II. A practical means for inducing and maintaining antibody formation. (1954) (49)
INDUCTION OF LONG-TERM IMMUNITY TO PARALYTIC POLIOMYELITIS BY USE OF NON-INFECTIOUS VACCINE (1984) (48)
A CONCEPT OF THE MECHANISM OF IMMUNITY FOR PREVENTING PARALYSIS IN POLIOMYELITIS (1955) (47)
Direction of research on vaccination against influenza; new studies with immunologic adjuvants. (1951) (46)
Importance of antigenic composition of influenza virus vaccine in protecting against the natural disease; observations during the winter of 1947-1948. (1949) (45)
Recent studies on immunization against poliomyelitis. (1953) (44)
The use of adjuvants in studies on influenza immunization. II. Increased antibody formation in human subjects inoculated with influenza virus vaccine in a water in-oil emulsion. (1952) (43)
Persistence of immunity after administration of formalin-treated poliovirus vaccine. (1960) (42)
One-dose immunization against paralytic poliomyelitis using a noninfectious vaccine. (1984) (41)
Poliomyelitis vaccine in the fall of 1955. (1956) (39)
Immunization Against Influenza. (1946) (39)
Vaccination against paralytic poliomyelitis performance and prospects. (1955) (39)
Immunity in Human Subjects Artificially Infected with Influenza Virus, Type B. (1944) (37)
Some characteristics of a continuously propagating cell derived from monkey heart tissue. (1957) (37)
Protective Effect of Vaccination Against Induced Influenza B.∗ (1944) (37)
Vaccinology of poliomyelitis. (1984) (36)
Observations after human immunodeficiency virus immunization and challenge of human immunodeficiency virus seropositive and seronegative chimpanzees. (1991) (35)
Theoretical and practical considerations in the application of killed poliovirus vaccine for the control of paralytic poliomyelitis. (1981) (33)
REQUIREMENTS FOR PERSISTENT IMMUNITY TO POLIOMYELITIS (1956) (31)
Antigen content of inactivated poliovirus vaccine for use in a one- or two-dose regimen. (1982) (31)
Development and Evaluation of a Vaccine for Human Immunodeficiency Virus (HIV) Infection (1989) (31)
Killed poliovirus antigen titration in humans. (1978) (27)
IMMUNOLOGICAL PARADOXES: THEORETICAL CONSIDERATIONS IN THE REJECTION OR RETENTION OF GRAFTS, TUMORS, AND NORMAL TISSUE (1969) (27)
Antigenic activity of poliomyelitis vaccines undergoing field test. (1955) (24)
Poliomyelitis vaccination in the fall of 1956. (1957) (24)
THE IMMUNIZING EFFECT OF CALCIUM PHOSPHATE ADSORBED INFLUENZA VIRUS. (1945) (24)
Immunization against influenza with observations during an epidemic of influenza A one year after vaccination. (1945) (22)
Can AIDS be prevented by T-cell vaccination? (1993) (22)
Reactions to concentrated influenza virus vaccines. (1948) (22)
How many injections of poliomyelitis vaccine for effective and durable immunity. (1958) (22)
Antigenic potency of poliomyelitis vaccine; influence on degree and duration of vaccine effect. (1956) (21)
Studies on poliomyelitis viruses in cultures of monkey testicular tissue. I. Propagation of virus in roller tubes. (1952) (21)
Mechanisms of autoimmunity and AIDS: prospects for therapeutic intervention (1994) (20)
Studies in human subjects on active immunization against poliomyelitis. I. A preliminary report of experiments in progress. (1953) (20)
Experience with vaccination against influenza in the spring of 1947; a preliminary report. (1947) (20)
Immunologic memory induced at birth by immunization with inactivated polio vaccine in a reduced schedule (1989) (19)
Principles of immunization as applied to poliomyelitis and influenza. (1953) (19)
THE ANTIGENIC POTENCY OF EPIDEMIC INFLUENZA VIRUS FOLLOWING INACTIVATION BY ULTRAVIOLET RADIATION (1940) (19)
IDENTIFICATION OF INFLUENZA VIRUS TYPE A IN CURRENT OUTBREAK OF RESPIRATORY DISEASE (1944) (18)
Interim report, Public Health Service Technical Committee on Poliomyelitis Vaccine. (1955) (17)
Partial Purification of the Virus of Epidemic Influenza by Adsorption on Calcium Phosphate.∗ (1941) (17)
A Plastic Plate for Use in Tests Involving Virus Hemagglutination and Other Similar Reactions. (1948) (16)
Detection and elimination of cellular nucleic acids in biologicals produced on continuous cell lines. (1981) (16)
The use of adjuvants to facilitate studies on the immunologic classification of poliomyelitis viruses. (1951) (16)
Induction of humoral and cellular immunity to simian immunodeficiency virus: what are the requirements for protection? (1994) (16)
Complexity, organization and uncertainty (1987) (16)
Preconceptions about vaccination against paralytic poliomyelitis. (1959) (15)
World Population and Human Values: A New Reality (1981) (13)
Studies on poliomyelitis viruses in cultures of monkey testicular tissue. II. Differences among strains in tissue culture infectivity with preliminary data on the quantitative estimation of virus and antibody. (1952) (13)
Propagation of poliovirus in microcarrier cultures of three monkey kidney cell lines. (1981) (12)
An interpretation of the significance of influenza virus variation for the development of an effective vaccine. (1952) (12)
Variation in Influenza Viruses. A Study of Heat Stability of the Red Cell Agglutinating Factor.∗ (1946) (12)
Poliomyelitis vaccine preparation and administration; analysis of basic premises and current practices. (1959) (11)
Immunization against poliomyelitis: risk/benefit/cost in a changing context. (1979) (10)
Present status of the problem of vaccination against poliomyelitis. (1955) (9)
Cell-mediated immunologic memory in prevention and treatment of HIV disease. (1994) (9)
Vaccination Against Poliomyelitis: an Ounce of Prevention (1959) (8)
SOME OBSERVATIONS ON MEASLES INDUCED GIANT CELL FORMATION. (1963) (8)
AIDS: The Medical Mystery (1984) (8)
Theoretical considerations and practical concerns regarding the use of continuous cell lines in the production of biologics. (1981) (8)
Studies on the antigenicity, in man, of calcium phosphate adsorbed influenza virus; with comments on the question of dose of virus needed in vaccines for human use. (1947) (8)
Serum demyelinating factors in multiple sclerosis (1983) (8)
REACTIONS TO INFLUENZA VIRUS VACCINES (1947) (7)
Are booster doses of poliovirus vaccine necessary? (1990) (7)
Poliomyelitis vaccination--choosing a wise policy. (1987) (7)
Physical aspects in the clinical implementation of the Enhanced Dynamic Wedge ( EDW ) (6)
Studies on Myelin Basic Protein Administration in Multiple Sclerosis Patients (1980) (6)
Viral load, CD4 percentage, and delayed-type hypersensitivity in subjects receiving the HIY-1 Immunogen and antiviral drug therapy (1996) (6)
Polio vaccines and polioviruses. (1977) (6)
Mechanisms Of Immunity In Virus Infections (1963) (5)
Studies of poliomyelitis viruses in cultures of monkey testicular tissue. III. Isolation and immunologic identification of poliomyelitis viruses from fecal specimens by means of roller tube cultures. (1952) (5)
A Method Applicable to the Standardization of Influenza Virus Vaccines.∗ (1947) (5)
Viral diseases; their control by immunologic means. (1961) (5)
How like an angel: Biology and the nature of man (1975) (4)
Effect of 5-Ammo-7-Hydroxy-lH-v-Triazolo (d) Pyrimidine on Growth and Development of the Chick Embryo.∗ (1950) (4)
Immunization against poliomyelitis. (1953) (4)
The virus of poliomyelitis. From discovery to extinction. (1983) (4)
The spector of malignancy and criteria for cell lines as substrates for vaccines. (1979) (3)
Evaluation of influenza vaccine in an explosive epidemic of mixed etiology. (1958) (3)
NIH conference. Development and evaluation of a vaccine for human immunodeficiency virus (HIV) infection. (1989) (3)
REINOCULATIONS OF POLIOMYELITIS VACCINE (1956) (3)
[Immunological classification of poliomyelitis viruses]. (1952) (3)
Next Steps in the Evolution of Vaccinology (1989) (3)
Effect of Formalin in Increasing Heat Stability of Influenza Virus Hemagglutinin.∗ (1946) (3)
Increases in Serum Lactate Dehydrogenase in Experimental Allergic Encephalomyelitis (1970) (3)
Immunotherapy of HIV-seropositive patients: preliminary report on a dose-ranging study. (1992) (3)
Evidence for dissociation of titer of infectious and antigenic activity in a preparation of the Lansing strain of poliomyelitis virus. (1951) (2)
Prospects for AIDS vaccines: the need for clinical trials in human populations. (1991) (2)
Monkey kidney cell growth optimization and poliovirus propagation in microcarrier culture. (1981) (2)
Immune response and minimum requirement for immunity to disease. (1982) (2)
POLIO IMMUNIZATION AND THE HERD EFFECT. (1963) (2)
THE WORLD WE WILL LIVE IN * (1971) (2)
Serial urinary Addis counts in patients inoculated repeatedly with poliomyelitis vaccine prepared from monkey kidney tissue cultures. (1955) (2)
CHAPTER 23 – Principles of Vaccinology in the Control of Virus Diseases: Poliomyelitis (1978) (2)
Vaccines for Poliomyelitis (1955) (2)
Verification of Lung and Kidney Shielding in Total Body Irradiation Using an EPID with Extended Image Detection Unit (2001) (1)
Calculation of effective Enhanced Dynamic Wedge Factors from Segmented Treatment Tables for symmetric and asymmetric photon beams (2003) (1)
Present status of the problem of vaccination against poliomyelitis. (1955) (1)
Immunologic classification of poliomyelitis viruses. IV. Results of typing by neutralization of prototype viruses with antiserum produced by vaccinating monkeys with unknown strain and an adjuvant. (1951) (1)
Influenza in Europe during the winter of 1945-46. (1946) (1)
Catching the Flu (1978) (1)
The control of influenza by immunization. (1947) (1)
Immunization Against Poliomyelitis. (1962) (1)
Poliomyelitis vaccination; practicalities for the practicing physician. (1955) (1)
Antibody titer for seven different type 1 strains of poliomyelitis virus in children vaccinated with the Mahoney strain. (1956) (1)
Immunization against influenza. (1946) (0)
Engineers and Professional Self-Regulation, Grant Jordan. 1992. Clarendon Press, Oxford. 305 pages. ISBN: 0-19-827747-4. $NA (1994) (0)
Immunologic classification of poliomyelitis viruses. III. Results obtained with the method of neutralization with prototype antisera. A. Preparation of antiserum pools. (1951) (0)
Vaccination Against Poliomyelitis. (1959) (0)
Immunologic classification of poliomyelitis viruses. III. Results obtained with the method of neutralization by prototype antisera. B. Studies from the University of Pittsburgh on twenty-three strains. (1951) (0)
Overview of cytokine climate, CD8 T cells and therapies in AID (1994) (0)
1950-51 -- Correspondence, Unsorted -- letter, 1950-12-18 (1950) (0)
Enterprise and Technology, Ulrich Wengenroth. 1993. Cambridge University Press, New York, NY. 295 pages. ISBN: 0-521-38425-7. $59.95 (1994) (0)
Brazil -- 1958-67 -- Correspondence, OPV International -- letter, 1958-02-12 (1958) (0)
Attenuated Strains of Polio Virus -- 1955-57 -- Correspondence, OPV Distribution -- letter, 1955-09-06 (1955) (0)
Landmark article Aug 6, 1955: Considerations in the preparation and use of poliomyelitis virus vaccine. By Jonas E. Salk. (1984) (0)
Prevention and treatment of a retro virus disease (1988) (0)
Merging intuition and reason (1984) (0)
1952 -- Correspondence, Miscellaneous -- letter, 1952-03-14 (1952) (0)
Request for Reprints on Virus Diseases. (1946) (0)
JOURNAL OF HUMAN ECOLOGY (1998) (0)
[The polio vaccination]. (1956) (0)
Prevention et traitement de maladies retrovirales (1988) (0)
Statement on OPV for Institute of Medicine -- 1959-77 -- Correspondence, OPV Miscellaneous -- letter, 1977-03-08 (1977) (0)
Further Discussion of Emergent Evolution (1992) (0)
To-day's Drugs (1959) (0)
Viral and rickettsial infections of the lung; comments on the problem of specific therapy. (1949) (0)
Immunologic comparison of different laboratory lines of the Lansing strain of poliomyelitis virus. (1951) (0)
New Era for Salk Institute? (1968) (0)
[The polio vaccination]. (1956) (0)
Ultraviolet Irradiation Experiments and Apparatus -- 1944-1947 -- Correspondence, Military Service, Dengue -- letter, 1944-05-17 (1944) (0)
1952 -- Correspondence, Unsorted -- letter, 1952-12-23 (1952) (0)
The logic of the magic of vaccination. (1988) (0)
The control of influenza by immunization. (1947) (0)
1951 -- Correspondence, Miscellaneous -- letter, 1951-08-24 (1951) (0)
744 ANTIGENICITY OF IRRADIATED INFLUENZA (0)
A simple Formalism for Calculation and Verification of Dose in Asymmetric X-ray Fields (0)
Requirements for persistent immunity to poliomyelitis. (1956) (0)
The French Worker, Mark Traugott. 1993. University of California Press, Berkeley, CA. 393 pages. ISBN: 0-520-07931-0 (hc); 0-520-07932-9 (pb). $50.00 (hc); $16.00 (pb (1994) (0)
Effect of 5-amino-7-hydroxy-1 H-v-triazolo (d) pyrimidine on growth and development of the chick embryo. (1950) (0)
American Medical Associaiton Symposium Prospects for the Control of Poliomyelitis -- 1955 -- Poliomyelitis, Conferences/Committees -- letter, 1955-06-03 (1955) (0)
Prevention and treatment of retroviral diseases produced (1989) (0)
How Vaccines Work: Different Patterns for Different Diseases (1992) (0)
1950-51 -- Correspondence, Unsorted -- letter, 1950-04-10 (1950) (0)
The restless spirit of Thomas Francis, Jr., still lives: the unsolved problems of recurrent influenza epidemics. (1970) (0)
U.S. Army, Sandfly Fever, Dengue -- 1945 -- Correspondence, Miscellaneous -- letter, 1945-03-31 (1945) (0)
Process for the preparation of the HIV-hiukkasimmunogeenin and its antibody (1989) (0)
Creativity as a distributed function (1988) (0)
Foolish idea (2001) (0)
PANEL DISCUSSION 2: THE IMMUNOLOGIC APPROACH (1969) (0)
In Vitro Diagnostic Tests for Poliomyelitis - The Infection and the Virus -- 1950 [C] -- Conferences and Special Meetings, NFIP -- letter, 1950-08-21 (1950) (0)
1950 -- Correspondence, Miscellaneous -- letter, 1950-12-05 (1950) (0)
Method for Separation of Micro-organisms from Large Quantities of Broth Culture (1938) (0)
[Study of non-pathogenic poliomyelitis vaccines]. (1954) (0)

This paper list is powered by the following services:

Other Resources About Jonas Salk

en.wikipedia.org

What Schools Are Affiliated With Jonas Salk?

Jonas Salk is affiliated with the following schools:

Image Attributions

Image Source for Jonas Salk